NADPH oxidase has a directional response to shear stress.
Vessel regions with predilection to atherosclerosis have negative wall shear stress due to flow reversal. The flow reversal causes the production of superoxides (O(2)(-)), which scavenge nitric oxide (NO), leading to a decrease in NO bioavailability and endothelial dysfunction. Here, we implicate NADPH oxidase as the primary source of O(2)(-) during full flow reversal. Nitrite production and the degree of vasodilation were measured in 46 porcine common femoral arteries in an ex vivo system. Nitrite production and vasodilation were determined before and after the inhibition of NADPH oxidase, xanthine oxidase, or mitochondrial oxidase. NADPH oxidase inhibition with gp91ds-tat or apocynin restored nitrite production and vasodilation during reverse flow. Xanthine oxidase inhibition increased nitrite production at the highest flow rate, whereas mitochondrial oxidase inhibition had no effect. These findings suggest that the NADPH oxidase system can respond to directional changes of flow and is activated to generate O(2)(-) during reverse flow in a dose-dependent fashion. These findings have important clinical implications for oxidative balance and NO bioavailability in regions of flow reversal in a normal and compromised cardiovascular system.
Godbole
Anjali S
AS
Dept. of Biomedical Engineering, Indiana Univ.-Purdue Univ. Indianapolis, IN 46202, USA.
Lu
Xiao
X
Guo
Xiaomei
X
Kassab
Ghassan S
GS
D000818:Animals; D001158:Arteries / Q000378:metabolism* / Q000503:physiopathology*; D015153:Blotting, Western; D006023:Glycoproteins / Q000494:pharmacology; D018613:Microscopy, Confocal; D019255:NADPH Oxidases / Q000378:metabolism*; D009569:Nitric Oxide / Q000096:biosynthesis / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism; D010117:Oxypurinol / Q000494:pharmacology; D013312:Stress, Physiological / Q000502:physiology*; D013481:Superoxides / Q000378:metabolism; D013552:Swine; D014664:Vasodilation / Q000502:physiology
D006023:Glycoproteins; D009573:Nitrites; C473031:gp91ds-tat protein, chimeric; D013481:Superoxides; D009569:Nitric Oxide; D019255:NADPH Oxidases; D010117:Oxypurinol